VRG Therapeutics Advances VRG-145, a Synergistic Oral Combination for Migraine Prophylaxis, to Final Preclinical Stage
VRG Therapeutics Advances VRG-145, a Novel Synergistic Oral Combination for Migraine Prophylaxis, to Final Preclinical Stage BUDAPEST, HUNGARY, April 17, 2024 /EINPresswire.com/ -- VRG Therapeutics (VRG Tx), a leading biotechnology research and …